- Home
- FNF vs DGX Comparison
FNF vs DGX Comparison
Compare FNF & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNF
- DGX
- Stock Information
- Founded
- FNF 1847
- DGX 1967
- Country
- FNF United States
- DGX United States
- Employees
- FNF N/A
- DGX N/A
- Industry
- FNF Specialty Insurers
- DGX Medical Specialities
- Sector
- FNF Finance
- DGX Health Care
- Exchange
- FNF Nasdaq
- DGX Nasdaq
- Market Cap
- FNF 15.4B
- DGX 17.5B
- IPO Year
- FNF N/A
- DGX 1996
- Fundamental
- Price
- FNF $59.48
- DGX $172.26
- Analyst Decision
- FNF Buy
- DGX Buy
- Analyst Count
- FNF 5
- DGX 13
- Target Price
- FNF $66.00
- DGX $177.69
- AVG Volume (30 Days)
- FNF 830.7K
- DGX 1.2M
- Earning Date
- FNF 02-20-2025
- DGX 01-30-2025
- Dividend Yield
- FNF 3.36%
- DGX 1.86%
- EPS Growth
- FNF 143.46
- DGX 2.67
- EPS
- FNF 4.65
- DGX 7.69
- Revenue
- FNF $13,681,000,000.00
- DGX $9,872,000,000.00
- Revenue This Year
- FNF N/A
- DGX $10.18
- Revenue Next Year
- FNF $6.26
- DGX $3.82
- P/E Ratio
- FNF $12.81
- DGX $22.37
- Revenue Growth
- FNF 16.06
- DGX 6.70
- 52 Week Low
- FNF $46.85
- DGX $123.66
- 52 Week High
- FNF $64.83
- DGX $172.91
- Technical
- Relative Strength Index (RSI)
- FNF 59.66
- DGX 70.79
- Support Level
- FNF $57.54
- DGX $166.15
- Resistance Level
- FNF $58.72
- DGX $172.64
- Average True Range (ATR)
- FNF 1.01
- DGX 3.27
- MACD
- FNF 0.11
- DGX 0.74
- Stochastic Oscillator
- FNF 58.59
- DGX 94.96
About FNF FNF Group of Fidelity National Financial Inc.
Fidelity National Financial Inc provides title insurance, escrow, and other title-related services. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. Substantially all of the company's revenue is generated in the United States.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.